Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Originally published at CNBC
Find More
Trending News
- Microsoft Bing to gain more personalized answers, support for DALLE-E 3, and watermarked AI images
- These stocks win when interest rates rise, according to Goldman
- United Auto Workers Strike Expands At General Motors And Stellantis
- Pope to Meet Macron in Marseille and Defend Migrants’ Plight
- The Man Who Trapped Us in Databases
- Chris Lehane: The SEC isn’t handling crypto regulation ‘strategically’
- Web3 Adventure Game Big Time Poised to Kickoff Its ‘Player-Owned Economy’
- Bill Ackman lays out a series of reasons why he’s betting rates keep rising — How you can play along
- Niura’s EEG-implemented earbuds scan your brain health and recommend music to your mood
- CFTC Denies Kalshi’s Plan to Let Users Bet on Control of U.S. Congress